Drug name - Nextstellis

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7732430 MAYNE PHARMA Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception Mar, 2025

(2 years from now)

Drugs and Companies using DROSPIRENONE; ESTETROL ingredient

Treatment: Use by females of reproductive potential to prevent pregnancy


More Information on Dosage
Strength Dosage Availability
3MG;14.2MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.